Weiping Jia

82PUBLICATIONS
191CO-AUTHORS
Food properties (incl. characteristics and health benefits)Epigenetics (incl. genome methylation and epigenomics)Electrochemical energy storage and conversionLiquid biopsiesExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (82)

|Sep 08, 2026
Optimised carbohydrate dietary intervention for improving metabolic health in adults with prediabetes: study protocol for a multicentre randomised controlled trial.

|May 25, 2026
GPSM1 restricts CD73+CD103+ Treg cells in adipose tissue, critical for promoting obesity-related metabolic deterioration.

|May 08, 2026
Efsubaglutide alfa added to metformin improves glycaemia with β-cell functional responses in type 2 diabetes: a randomised, double-blind, placebo-controlled, two-stage adaptive phase 2b/3 trial (SUPER 2).

|Feb 11, 2026
Efsubaglutide alfa in adults with overweight or obesity: Protocol for a seamless, adaptive phase 2b/3 randomized, double-blind, placebo-controlled trial (LIGHT 2).

Weiping Jia, Qinghua Wang

|Jan 06, 2026
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double-blind, placebo-controlled, ascending-dose phase 2a trial.

Fei Gao, Mingxia Yuan, Nianrong Mi

|Dec 30, 2025
Guidelines on primary healthcare for type 2 diabetes in China, 2025.

Weiping Jia, Dalong Zhu, Lixin Guo

Pageof 14

Frequent Collaborators

14 joint publications

Huating Li

10 joint publications

Yuqian Bao

8 joint publications

Cheng Hu

8 joint publications

Bin Sheng